| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Pathology,
*
Obstetrics and Gynecology,
and Anatomy,
Hong Kong Jockey Club Clinical Research Centre, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
The methylation status of genes in hydatidiform mole and choriocarcinoma and its significance is relatively unexplored. We investigated the methylation status of the promoter regions of six genes, p16, HIC-1, TIMP3, GSTP1, death-associated protein kinase (DAPK), and E-cadherin in 54 hydatidiform moles, five choriocarcinomas, and 10 first trimester placenta by methylation-specific polymerase chain reaction (PCR). Immunohistochemical expression of p16, TIMP3, and E-cadherin, and quantitative real-time RT-PCR of p16 was also performed. Among the six genes examined, the promoter region of four genes (E-cadherin, HIC-1, p16, TIMP3) in choriocarcinoma and three genes (E-cadherin, HIC-1, p16) in hydatidiform mole exhibited aberrant methylation whereas none was hypermethylated in normal placenta. There was a significant correlation between methylation and reduced expression of p16, E-cadherin, and TIMP3 (P < 0.001). Fifteen of the 54 patients with hydatidiform mole developed gestational trophoblastic neoplasia requiring chemotherapy. Promoter hypermethylation of p16 alone, or combined with E-cadherin, was significantly correlated to such development (P = 0.001, 0.0005, respectively). Hypermethylation of multiple genes, especially p16, might be related to the subsequent development of gestational trophoblastic neoplasia.
This article has been cited by other articles:
 |
|
 |
|
  I.-M. Shih and K.-T. Kuo Power of the Eternal Youth: Nanog Expression in the Gestational Choriocarcinoma Am. J. Pathol., October 1, 2008; 173(4): 911 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S.M. Li, M. K.Y. Siu, HuiJuan Zhang, E. S.Y. Wong, K. Y.K. Chan, H. Y.S. Ngan, and A. N.Y. Cheung Hypermethylation of SOX2 Gene in Hydatidiform Mole and Choriocarcinoma Reproductive Sciences, September 1, 2008; 15(7): 735 - 744. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Novakovic, V. Rakyan, H.K. Ng, U. Manuelpillai, C. Dewi, N.C. Wong, R. Morley, T. Down, S. Beck, J.M. Craig, et al. Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts Mol. Hum. Reprod., September 1, 2008; 14(9): 547 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W.K. Chiu, S. S.C. Chim, I. H.N. Wong, C. S.C. Wong, W.-S. Lee, K. F. To, J. H.M. Tong, R. K.C. Yuen, A. S.W. Shum, J. K.C. Chan, et al. Hypermethylation of RASSF1A in Human and Rhesus Placentas Am. J. Pathol., March 1, 2007; 170(3): 941 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P M Chiu, H C Feng, D M Benbrook, H Y S Ngan, U S Khoo, W C Xue, S W Tsao, K W Chan, and A N Y Cheung Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model J. Clin. Pathol., August 1, 2006; 59(8): 845 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S C C Wong, A T C Chan, J K C Chan, and Y M D Lo Nuclear {beta}-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form J. Clin. Pathol., April 1, 2006; 59(4): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Shen, K. Y.-K. Chan, U.-S. Khoo, H. Y.-S. Ngan, W.-C. Xue, P.-M. Chiu, P. Ip, and A. N.-Y. Cheung Epigenetic and genetic alterations of p33ING1b in ovarian cancer Carcinogenesis, April 1, 2005; 26(4): 855 - 863. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
